EP03.03. Impact of Tyrosine Kinase Inhibitors on the Immune Response to SARS CoV2 Vaccination in Patients with Non Small Cell Lung Cancer - PDF(Slides)
Back to course
Pdf Summary
Asset Subtitle
Norma Hernández Pedro
Meta Tag
Speaker Norma Hernández Pedro
Topic Tumor Biology: Translational Biology - IO
tyrosine kinase inhibitors
immune response
SARS-CoV-2 vaccination
non-small cell lung cancer
targeted therapy
COVID-19 vaccine
antibody synthesis
B-cell subpopulations
EGFR mutations
ALK alterations
Powered By